Table 3 Secondary outcome measures selected and reported in pediatric EoE trials

_{Esophageal eosinophilia}

_X

_X

_{Endoscopic features}

_X

_X

_{Modified endocscopy tool}

_X

_X

_{Histologic features}

_X

_X

_{Histology Scoring Tool}

_X

_{Severity score for endoscopy and histology}

_X

_{Clinical symptoms}

_X

_{Predominant symptom assessment scores (patient report)}

_X

_{“Clinical Response” (combined patient report and physician assessment)}

_X

_{Symptom scoring tool}

_X

_X

_{EoE symptom scoring tool}

_{Pediatric EoE symptom severity module}

_X

_{CHQ scores}

_X

_PedsQL

_X

_{Genotypic features}

_X

_{Blood eosinophil counts}

_X

_{Immune features}

_X

_X

_{Proteonomic features}

_X

_X

_X

_{Profile of durability of response to treatment}

_X

_{Adverse events}

_X